Association between anti-TNF-α therapy and interstitial lung disease
Version of Record online: 29 JAN 2013
Copyright © 2013 John Wiley & Sons, Ltd.
Pharmacoepidemiology and Drug Safety
Volume 22, Issue 4, pages 394–402, April 2013
How to Cite
Herrinton, L. J., Harrold, L. R., Liu, L., Raebel, M. A., Taharka, A., Winthrop, K. L., Solomon, D. H., Curtis, J. R., Lewis, J. D. and Saag, K. G. (2013), Association between anti-TNF-α therapy and interstitial lung disease. Pharmacoepidem. Drug Safe., 22: 394–402. doi: 10.1002/pds.3409
- Issue online: 1 APR 2013
- Version of Record online: 29 JAN 2013
- Manuscript Accepted: 25 DEC 2012
- Manuscript Revised: 14 DEC 2012
- Manuscript Received: 17 AUG 2012
Additional supporting information may be found in the online version of this article.
|pds_3409_supplementary_material.doc||Word document||230K||Supporting Information|
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.